Skip to main content
. 2021 Aug 26;11:739171. doi: 10.3389/fonc.2021.739171

Figure 2.

Figure 2

Cumulative incidence of mortality related to CML (A) or to other causes of deaths (B) treated as a competing event, according to front-line TKI treatment.